Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 4.17
RVP's Cash-to-Debt is ranked higher than
63% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. RVP: 4.17 )
Ranked among companies with meaningful Cash-to-Debt only.
RVP' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 5.22 Max: 24.08
Current: 4.17
0.06
24.08
Equity-to-Asset 0.71
RVP's Equity-to-Asset is ranked higher than
69% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. RVP: 0.71 )
Ranked among companies with meaningful Equity-to-Asset only.
RVP' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.01  Med: 0.73 Max: 0.86
Current: 0.71
0.01
0.86
Debt-to-Equity 0.13
RVP's Debt-to-Equity is ranked higher than
74% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.35 vs. RVP: 0.13 )
Ranked among companies with meaningful Debt-to-Equity only.
RVP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.13 Max: 62.98
Current: 0.13
0.04
62.98
Debt-to-EBITDA -1.04
RVP's Debt-to-EBITDA is ranked lower than
99.99% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. RVP: -1.04 )
Ranked among companies with meaningful Debt-to-EBITDA only.
RVP' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.41  Med: -0.81 Max: 1.19
Current: -1.04
-3.41
1.19
Piotroski F-Score: 2
Altman Z-Score: 0.89
Beneish M-Score: -3.42
WACC vs ROIC
4.15%
-27.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -14.45
RVP's Operating Margin % is ranked lower than
72% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.72 vs. RVP: -14.45 )
Ranked among companies with meaningful Operating Margin % only.
RVP' s Operating Margin % Range Over the Past 10 Years
Min: -37.83  Med: -15.57 Max: -6.25
Current: -14.45
-37.83
-6.25
Net Margin % -15.01
RVP's Net Margin % is ranked lower than
72% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. RVP: -15.01 )
Ranked among companies with meaningful Net Margin % only.
RVP' s Net Margin % Range Over the Past 10 Years
Min: -34.57  Med: -12.34 Max: 14.6
Current: -15.01
-34.57
14.6
ROE % -18.44
RVP's ROE % is ranked lower than
74% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.68 vs. RVP: -18.44 )
Ranked among companies with meaningful ROE % only.
RVP' s ROE % Range Over the Past 10 Years
Min: -27.63  Med: -14.26 Max: 20.52
Current: -18.44
-27.63
20.52
ROA % -11.63
RVP's ROA % is ranked lower than
72% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.36 vs. RVP: -11.63 )
Ranked among companies with meaningful ROA % only.
RVP' s ROA % Range Over the Past 10 Years
Min: -16.75  Med: -8.84 Max: 9.84
Current: -11.63
-16.75
9.84
ROC (Joel Greenblatt) % -26.93
RVP's ROC (Joel Greenblatt) % is ranked lower than
72% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.63 vs. RVP: -26.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
RVP' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -66.55  Med: -23.48 Max: 33.35
Current: -26.93
-66.55
33.35
3-Year Revenue Growth Rate -3.80
RVP's 3-Year Revenue Growth Rate is ranked lower than
73% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.90 vs. RVP: -3.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
RVP' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.9  Med: 1.25 Max: 15.1
Current: -3.8
-7.9
15.1
3-Year EBITDA Growth Rate -19.60
RVP's 3-Year EBITDA Growth Rate is ranked lower than
82% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. RVP: -19.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
RVP' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -71.1  Med: -28.7 Max: 285.6
Current: -19.6
-71.1
285.6
3-Year EPS without NRI Growth Rate -16.80
RVP's 3-Year EPS without NRI Growth Rate is ranked lower than
76% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. RVP: -16.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
RVP' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -35.6  Med: -16.8 Max: 56.5
Current: -16.8
-35.6
56.5
GuruFocus has detected 3 Warning Signs with Retractable Technologies Inc RVP.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» RVP's 30-Y Financials

Financials (Next Earnings Date: 2018-02-14 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

RVP Guru Trades in Q4 2016

Jim Simons 69,400 sh (+28.28%)
» More
Q1 2017

RVP Guru Trades in Q1 2017

Jim Simons 91,600 sh (+31.99%)
» More
Q2 2017

RVP Guru Trades in Q2 2017

Jim Simons 109,300 sh (+19.32%)
» More
Q3 2017

RVP Guru Trades in Q3 2017

Jim Simons 140,400 sh (+28.45%)
» More
» Details

Insider Trades

Latest Guru Trades with AMEX:RVP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:OSTO:BIOS, NAS:CASM, XKLS:0182, OTCPK:REPR, ROCO:6527, ROCO:6493, NAS:BMRA, OTCPK:STXS, OTCPK:NEPH, NAS:VLRX, OTCPK:THCT, XKLS:7191, OTCPK:UEEC, AMEX:DXR, TSE:3604, XPAR:SAFOR, BSP:BALM3, TSE:7813, WAR:MMD, XSAT:HEART » details
Headquarter Location:USA
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes; 3mL and 10mL VanishPoint syringes.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes; 3mL and 10mL VanishPoint syringes.

Ratios

vs
industry
vs
history
PB Ratio 0.78
RVP's PB Ratio is ranked higher than
92% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. RVP: 0.78 )
Ranked among companies with meaningful PB Ratio only.
RVP' s PB Ratio Range Over the Past 10 Years
Min: 0.27  Med: 1.11 Max: 5.62
Current: 0.78
0.27
5.62
PS Ratio 0.65
RVP's PS Ratio is ranked higher than
89% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.36 vs. RVP: 0.65 )
Ranked among companies with meaningful PS Ratio only.
RVP' s PS Ratio Range Over the Past 10 Years
Min: 0.39  Med: 1.24 Max: 4.26
Current: 0.65
0.39
4.26
EV-to-EBIT -2.40
RVP's EV-to-EBIT is ranked lower than
99.99% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.17 vs. RVP: -2.40 )
Ranked among companies with meaningful EV-to-EBIT only.
RVP' s EV-to-EBIT Range Over the Past 10 Years
Min: -97.9  Med: -1.7 Max: 220.8
Current: -2.4
-97.9
220.8
EV-to-EBITDA -2.95
RVP's EV-to-EBITDA is ranked lower than
99.99% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.83 vs. RVP: -2.95 )
Ranked among companies with meaningful EV-to-EBITDA only.
RVP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1714.2  Med: -2.1 Max: 23.3
Current: -2.95
-1714.2
23.3
EV-to-Revenue 0.34
RVP's EV-to-Revenue is ranked higher than
97% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. RVP: 0.34 )
Ranked among companies with meaningful EV-to-Revenue only.
RVP' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.5  Med: 0.7 Max: 3.8
Current: 0.34
-0.5
3.8
Current Ratio 3.31
RVP's Current Ratio is ranked higher than
63% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. RVP: 3.31 )
Ranked among companies with meaningful Current Ratio only.
RVP' s Current Ratio Range Over the Past 10 Years
Min: 0.55  Med: 3.82 Max: 11.46
Current: 3.31
0.55
11.46
Quick Ratio 2.34
RVP's Quick Ratio is ranked higher than
65% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. RVP: 2.34 )
Ranked among companies with meaningful Quick Ratio only.
RVP' s Quick Ratio Range Over the Past 10 Years
Min: 0.22  Med: 2.98 Max: 10.86
Current: 2.34
0.22
10.86
Days Inventory 125.58
RVP's Days Inventory is ranked higher than
53% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.23 vs. RVP: 125.58 )
Ranked among companies with meaningful Days Inventory only.
RVP' s Days Inventory Range Over the Past 10 Years
Min: 84.36  Med: 112.71 Max: 133.86
Current: 125.58
84.36
133.86
Days Sales Outstanding 41.01
RVP's Days Sales Outstanding is ranked higher than
82% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.37 vs. RVP: 41.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
RVP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.16  Med: 42.75 Max: 93.15
Current: 41.01
23.16
93.15
Days Payable 77.90
RVP's Days Payable is ranked higher than
69% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.31 vs. RVP: 77.90 )
Ranked among companies with meaningful Days Payable only.
RVP' s Days Payable Range Over the Past 10 Years
Min: 59.27  Med: 87.42 Max: 113.99
Current: 77.9
59.27
113.99

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -3.00
RVP's 3-Year Average Share Buyback Ratio is ranked higher than
55% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.10 vs. RVP: -3.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
RVP' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -14.6  Med: -2.55 Max: -0.3
Current: -3
-14.6
-0.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 5.50
RVP's Price-to-Net-Cash is ranked higher than
79% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.35 vs. RVP: 5.50 )
Ranked among companies with meaningful Price-to-Net-Cash only.
RVP' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.2  Med: 2.63 Max: 424.5
Current: 5.5
1.2
424.5
Price-to-Net-Current-Asset-Value 1.38
RVP's Price-to-Net-Current-Asset-Value is ranked higher than
97% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.73 vs. RVP: 1.38 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
RVP' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.81  Med: 1.92 Max: 100.33
Current: 1.38
0.81
100.33
Price-to-Tangible-Book 0.78
RVP's Price-to-Tangible-Book is ranked higher than
93% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.82 vs. RVP: 0.78 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
RVP' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.45  Med: 1.38 Max: 603.85
Current: 0.78
0.45
603.85
Price-to-Intrinsic-Value-Projected-FCF 5.08
RVP's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
85% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. RVP: 5.08 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
RVP' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.18  Med: 2.29 Max: 154
Current: 5.08
0.18
154
Price-to-Median-PS-Value 0.52
RVP's Price-to-Median-PS-Value is ranked higher than
88% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. RVP: 0.52 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
RVP' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.47  Med: 2.07 Max: 9.57
Current: 0.52
0.47
9.57
Earnings Yield (Greenblatt) % -41.67
RVP's Earnings Yield (Greenblatt) % is ranked lower than
97% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. RVP: -41.67 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
RVP' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -39842.9  Med: -16.9 Max: 15871.2
Current: -41.67
-39842.9
15871.2

More Statistics

Revenue (TTM) (Mil) $30.90
EPS (TTM) $ -0.17
Beta0.26
Short Percentage of Float0.29%
52-Week Range $0.54 - 2.59
Shares Outstanding (Mil)32.67

Piotroski F-Score Details

Piotroski F-Score: 22
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}